Published in Neural Regen Res on April 01, 2015
Regulation of TRPM7 Function by IL-6 through the JAK2-STAT3 Signaling Pathway. PLoS One (2016) 0.75
A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83
Interleukin-6 and the acute phase response. Biochem J (1990) 7.97
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J (1990) 5.16
Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol (2012) 2.46
Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci (1995) 2.28
Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev (1997) 2.08
Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci (2012) 2.01
Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials. Prog Neurobiol (1997) 1.83
Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol (1992) 1.78
Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol (1999) 1.67
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 1.63
Different signaling pathways mediate regenerative versus developmental sensory axon growth. J Neurosci (2001) 1.55
The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci (2006) 1.51
Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci (2007) 1.51
Cytokine actions in the central nervous system. Cytokine Growth Factor Rev (1999) 1.38
Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci (1993) 1.31
Glutamate release and neuronal damage in ischemia. Life Sci (2001) 1.22
Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma (2002) 1.18
Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci (1992) 1.16
Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci U S A (2000) 1.15
S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma (2001) 1.15
Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med (2003) 1.13
The biology of interleukin-6. Chem Immunol (1992) 1.13
Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.13
Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res (2001) 1.11
Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia (2000) 1.09
Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci (2003) 1.05
Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J Neurosci (1999) 0.93
Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias. Neurodegener Dis (2011) 0.93
Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab (1999) 0.91
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia (2014) 0.91
Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. J Neurophysiol (2002) 0.87
Altered physiology of Purkinje neurons in cerebellar slices from transgenic mice with chronic central nervous system expression of interleukin-6. Neuroscience (1999) 0.84
Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels. Mol Interv (2007) 0.83
Free fatty acid palmitate impairs the vitality and function of cultured human bladder smooth muscle cells. PLoS One (2012) 0.83
"Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies. Rheumatol Int (2011) 0.80
Chronic haloperidol increases voltage-gated Na+ currents in mouse cortical neurons. Biochem Biophys Res Commun (2014) 0.80
Effects of astrocyte-targeted production of interleukin-6 in the mouse on the host response to nerve injury. Glia (2014) 0.78
Ionic channels: molecular pores of excitable membranes. Harvey Lect (1988) 0.78
Adult meningism and viral meningitis, 1997-2004: clinical data and cerebrospinal fluid cytokines. Intern Med (2006) 0.77